IP Verse

Process For Concentration Of Antibodies And Therapeutic Products Thereof - EP3805248

The patent EP3805248 was granted to Genentech on Jan 18, 2023. The application was originally filed on Sep 8, 2005 under application number EP20200642A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3805248

GENENTECH
Application Number
EP20200642A
Filing Date
Sep 8, 2005
Status
Granted And Under Opposition
Dec 16, 2022
Publication Date
Jan 18, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KILBURN & STRODEOct 18, 2023KILBURN & STRODEADMISSIBLE
CELLTRIONOct 16, 2023HOFFMANN EITLEADMISSIBLE

Patent Citations (55) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2001US20118
DESCRIPTIONWO2001US25464
DESCRIPTIONWO2001US26626
DESCRIPTIONWO2002US12206
DESCRIPTIONWO2002US12619
DESCRIPTIONWO2002US19592
DESCRIPTIONWO2002US28859
DESCRIPTIONWO2002US33050
DESCRIPTIONWO2002US41798
DESCRIPTIONWO2003US11148
DESCRIPTIONJPH01268646
DESCRIPTIONUS2002122797
DESCRIPTIONUS4816567
DESCRIPTIONUS5545806
DESCRIPTIONUS5545807
DESCRIPTIONUS5569825
DESCRIPTIONUS5591669
DESCRIPTIONUS5625126
DESCRIPTIONUS5633425
DESCRIPTIONUS5641870
DESCRIPTIONUS5661016
DESCRIPTIONUS6172213
DESCRIPTIONUS6252055
DESCRIPTIONUS6582959
DESCRIPTIONWO9110741
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9717852
DESCRIPTIONWO9824893
EXAMINATIONWO0230463
EXAMINATIONWO2004091658
EXAMINATIONWO9704801
OPPOSITIONEP1610820
OPPOSITIONEP1786830
OPPOSITIONEP2292636
OPPOSITIONEP2335725
OPPOSITIONEP3805248
OPPOSITIONUS2002045571
OPPOSITIONUS4374763
OPPOSITIONUS6172213
OPPOSITIONWO0230463
OPPOSITIONWO2004091658
OPPOSITIONWO2006031560
OPPOSITIONWO9704801
OTHEREP1610820
OTHEREP2335725
OTHERUS6172213
OTHERWO0230463
OTHERWO2004091658
OTHERWO9901556
SEARCHUS2002045571
SEARCHUS2004167320
SEARCHUS5177194
SEARCHWO03042344
SEARCHWO2004042012

Non-Patent Literature (NPL) Citations (50) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, Marcel Dekker, Inc., (19870000), pages 51 - 63
DESCRIPTION- BRUGGEMANN et al., Year in Immuno., (19930000), vol. 7, page 33
DESCRIPTION- CHOTHIALESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
DESCRIPTION- "Downstream Processing in Biotechnology", R. HATTI-KAUL et al., Basic Biotechnology, Cambridge University Press, (20010000), pages 187 - 211
DESCRIPTION- FELLOUSE, Proc. Nat. Acad. Sci. USA, (20040000), vol. 101, no. 34, pages 12467 - 12472
DESCRIPTION- FISHWILD et al., Nature Biotechnology, (19960000), vol. 14, pages 826 - 851
DESCRIPTION- Goding, Monoclonal Antibodies: Principles and Practice, Academic Press, (19860900), pages 59 - 103
DESCRIPTION- HAMMERLING et al., Monoclonal Antibodies and T-Cell Hybridomas, Elsevier, (19810000), pages 563 - 681
DESCRIPTION- JAKOBOVITS et al., Nature, (19930000), vol. 362, pages 255 - 258
DESCRIPTION- JAKOBOVITS et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, page 2551
DESCRIPTION- JONES et al., Nature, (19860000), vol. 321, pages 522 - 525
DESCRIPTION- KOHLERMILSTEIN, Nature, (19750000), vol. 256, page 495
DESCRIPTION- KOZBOR, J. Immunol., (19840000), vol. 133, page 3001
DESCRIPTION- LEE et al., J. Immunol. Methods, (20040000), vol. 284, no. 1-2, pages 119 - 132
DESCRIPTION- LONBERG et al., Nature, (19940000), vol. 368, pages 812 - 813
DESCRIPTION- LONBERGHUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93
DESCRIPTION- MARKS et al., Bio/Technolo, (19920000), vol. 10, pages 779 - 783
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597
DESCRIPTION- MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 6851 - 6855
DESCRIPTION- PLUCKTHUN, The Pharmacology of Monoclonal Antibodies, Springer-Verlag, (19940000), vol. 113, pages 269 - 315
DESCRIPTION- PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596
DESCRIPTION- REICHMANN et al., Nature, (19880000), vol. 332, pages 323 - 329
DESCRIPTION- R. HATTI-KAUL et al., "Downstream Processing in Biotechnology", Basic Biotechnology
DESCRIPTION- SIDHU et al., J. Mol. Biol., (20040000), vol. 340, no. 5, pages 1 073 - 1093
DESCRIPTION- WANG, Y.-C. J. et al., "Parenteral formulations of proteins and peptides: stability and stabilizers", J. Parenteral Sci. Technol., (19880000), vol. 42
DESCRIPTION- ZAPATA et al., Protein Eng.., (19950000), vol. 8, no. 10, pages 1057 - 1062
DESCRIPTION- R. VAN REIS et al., "Constant C Ultrafiltration Process Control", J. of Membrane Science, (19970000), vol. 130, doi:10.1016/S0376-7388(97)00012-4, pages 123 - 140, XP004084451
EXAMINATION- LIU JUN ET AL, "Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution", JOURNAL OF PHARMACEUTICAL SCIENCES, AMERICAN CHEMICAL SOCIETY AND AMERICAN PHARMACEUTICAL ASSOCIATION, US, vol. 94, no. 9, doi:10.1002/JPS.20347, ISSN 0022-3549, (20050901), pages 1928 - 1940, (20050728), XP002578902
EXAMINATION- SANDEEP YADAV ET AL, "Establishing a Link Between Amino Acid Sequences and Self-Associating and Viscoelastic Behavior of Two Closely Related Monoclonal Antibodies", PHARMACEUTICAL RESEARCH, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NL, (20110406), vol. 28, no. 7, doi:10.1007/S11095-011-0410-0, ISSN 1573-904X, pages 1750 - 1764, XP019912566
EXAMINATION- DHEERAJ S. TOMAR ET AL, "In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions", MABS, US, (20170126), vol. 9, no. 3, doi:10.1080/19420862.2017.1285479, ISSN 1942-0862, pages 476 - 489, XP055739058
OPPOSITION- Anonymous, "XOLAIR® Omalizumab", FDA label, (20030101), XP093167260
OPPOSITION- Anonymous, "XOLAIR® Omalizumab - For Subcutaneous Use ", Genentech, (20030101), XP093204397
OPPOSITION- SHIRAKI KENTARO ET AL, "Biophysical effect of amino acids on the prevention of protein aggregation.", Journal of Biochemistry, Oxford University Press, GB, GB , (20021001), vol. 132, no. 4, ISSN 0021-924X, pages 591 - 595, XP002538261
OPPOSITION- United States Pharmacopeial Convention; United States Adopted Names Council, "MECLO-MECOB", USP DICTIONARY - DI USAN and International Drug Names, US, United States Pharmacopeial Convention; United States Adopted Names Council, (20030501), page 519, ISBN 1889788244, XP009557041
OPPOSITION- WANG W; SINGH S; ZENG D L; KING K; NEMA S, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, US , (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505
OPPOSITION- WANG W; SINGH S; ZENG D L; KING K; NEMA S, "ANTIBODY STRUCTURE, INSTABILITY, AND FORMULATION", Journal of Pharmaceutical Sciences, Wiley, United States, United States, (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505
OPPOSITION- Rajiv Nayar, Mark C. Manning, "High Throughput Formulation: Strategies for Rapid Development of Stable Protein Products", PHARMACEUTICAL BIOTECHNOLOGY, NL , KLUWER, DORDRECHT , (20020101), vol. 13, pages 177 - 198, doi:10.1007/978-1-4615-0557-0_8, ISSN 1078-0467, XP055764066
OPPOSITION- Rajiv Nayar & Mark C. Manning, "High Throughput Formulation: Strategies for Rapid Development of Stable Protein Products", Rational Design of Stable Protein Formulations, pages 177 - 198, XP055764066
OPPOSITION- Daugherty, A.L. Mrsny, R.J., "Formulation and delivery issues for monoclonal antibody therapeutics", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL , (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2006.03.011, ISSN 0169-409X, pages 686 - 706, XP005611422
OPPOSITION- Daugherty, A.L. ; Mrsny, R.J., "Formulation and delivery issues for monoclonal antibody therapeutics", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL , (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2006.03.011, ISSN 0169-409X, pages 686 - 706, XP024892149
OPPOSITION- Qiang Xie, "The guanidine like effects of arginine on aminoacylase and salt-induced molten globule state", International Journal of Biochemistry and Cell Biology, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (20040201), vol. 36, no. 2, doi:10.1016/S1357-2725(03)00252-8, ISSN 1357-2725, pages 296 - 306, XP093167259
OPPOSITION- TSUMOTO KOUHEI, ET AL, "Role of arginine in protein refolding, solubilization, and purification", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20040901), vol. 20, no. 5, doi:10.1021/bp0498793, ISSN 8756-7938, pages 1301 - 1308, XP002383385
OPPOSITION- Dheeraj S. Tomar, Li Li, Matthew P. Broulidakis, Nicholas G. Luksha, Christopher T. Burns, Satish K. Singh, Sandeep Kumar, "In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions", mAbs, Landes Bioscience, US, US , (20170403), vol. 9, no. 3, doi:10.1080/19420862.2017.1285479, ISSN 1942-0862, pages 476 - 489, XP055739058
OPPOSITION- Dent Gordon, "IgE modulation in asthma", EXPERT OPINION ON THERAPEUTIC PATENTS, Taylor & Francis, GB, GB , (20031001), vol. 13, no. 10, doi:10.1517/13543776.13.10.1607, ISSN 1354-3776, pages 1607 - 1617, XP093192554
SEARCH- "Protein Concentration and Buffer Exchange Using", Zydney L. Andrew and Ralf Kuriyel, Methods in Biotechnology: Downstream processing of proteins - Edited by Mohamed A. Desai, Totowa, NJ, Humana Press, (20000101), vol. 9, pages 23 - 34, XP002802202 [Y] 1-16,21 * Item 10; page 33 *
SEARCH- SCHWARTZ L., "Diafiltration: a fast, efficient, method for desalting, or buffer exchange of biological samples", (2003), PALL LIFE SCIENCES, URL: [email protected], (20060412), XP002376846 [Y] 1-16 * the whole document *
SEARCH- UNKNOWN, "Protein concentration and diafiltration by tangential flow filtration", (2003), MILLIPORE, URL: www.millipore.com, (20060412), XP002376847 [Y] 1-16 * the whole document *
SEARCH- ARNOLDUS W.P. VERMEER ET AL, "The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein", BIOPHYSICAL JOURNAL, AMSTERDAM, NL, (20000101), vol. 78, no. 1, doi:10.1016/S0006-3495(00)76602-1, ISSN 0006-3495, pages 394 - 404, XP055518561 [Y] 1-16 * page 397, column l *
SEARCH- CHEN BEI ET AL, "Influence of histidine on the stability and physical properties of a fully human antibody in aqueous and solid forms", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, (20031201), vol. 20, no. 12, doi:10.1023/B:PHAM.0000008042.15988.C0, ISSN 0724-8741, pages 1952 - 1960, XP002386671 [Y] 17-20 * page 1953, column l, paragraph last - page 1954, column l, paragraph first *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents